Oncology Institute Inc (TOI) USD0.0001

- Add to watchlist
- This stock can be held in a




Business summary
The Oncology Institute, Inc. is an oncology company. The Company manages community-based oncology practices that serve patients at approximately 67 clinic locations across 10 markets and four states throughout the United States. The Company’s managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, clinical trial services, programs like outpatient stem cell transplants and transfusions, along with 24/7 patient support. Through the Innovative Clinical Research Institute (ICRI), the Company also provides and manages clinical trial services and research for the benefit of cancer patients. The Company provides service, such as managing clinical trials, palliative care programs and stem cell transplants, are accessed through academic and tertiary care settings. Its managed clinics primarily serve adult and senior cancer patients in markets that have Medicare Advantage (MA) plans.
Contact details
Important dates
General stock information
- Short code:
- TOI
- ISIN:
- US68236X1000
- Market cap:
- $523.93 million
- Shares in issue:
- 73.28 million
- Sector:
- Health Care Facilities
- Exchange:
- NASDAQ
- Country:
- United States
- Currency:
- US dollar
- Indices:
- n/a
Key personnel

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.